Ammonium Chloride
Active ingredient · 2 therapeutic classes
Sold as CALMYLIN · Ammonium Muriaticum · DAMYLIN AVEC CODEINE SIROP
- Drug class
- Electrolyte Solutions
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 5
- FDA reports (12 mo)
- 44
Overview
Plain-language summary, compiled from the cited regulatory records
Ammonium Chloride is an active ingredient classified as an Electrolyte Solution [1]. It is available under various brand names, including Ammonium Muriaticum [1].
This ingredient is not approved for any specific medical conditions according to the provided data [1].
In the last 12 months, there have been 44 adverse event reports associated with Ammonium Chloride [2]. The most frequently reported adverse events include prolonged activated partial thromboplastin time, congenital hiatus hernia, chronic obstructive pulmonary disease, diabetes mellitus, and drug hypersensitivity [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 4 | July 10, 2025 |
| US United States | FDA | 1 | July 13, 2023 |
CACanada· Health Canada
4 products
Side effects & warnings
Adverse reactions due to codeine phosphate may include drowsiness, nausea, vomiting and constipation. Infrequent adverse effects include palpitation, dry mouth, skin rash, pruritus and, rarely, hyperhidrosis and agitation have been reported.
Respiratory depression is seen in higher dosage, and there is a potential for tolerance, psychological dependence or physical dependence to occur. Diphenhydramine delivers a sedative effect. Alcohol and other CNS depressants may increase this effect.
REPORTING SUSPECTED SIDE EFFECTS To monitor drug safety, Health Canada through the Canada Vigilance Program collects information on serious and unexpected effects of drugs. ca/medeffect.
NOTE:
Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice. 13 SYMPTOMS AND TREATMENT OF OVERDOSAGE In Case of Accidental Overdose: Call a Poison Control Centre or doctor immediately, even if you do not notice any signs or symptoms such as increased sweating, nausea, vomiting, stomach pain or loss of appetite.
USUnited States· FDA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Most-reported reactions to the US regulator (12 mo to June 4, 2026): 44 reports total. [3]
- Activated Partial Thromboplastin Time Prolonged 38
- Congenital Hiatus Hernia 35
- Chronic Obstructive Pulmonary Disease 34
- Diabetes Mellitus 34
- Drug Hypersensitivity 34
- Drug Intolerance 34
- General Physical Health Deterioration 34
- Hyperphosphataemia 34
- Hypophosphataemia 34
- Multiple Organ Dysfunction Syndrome
Drug interactions
Known interactions involving Ammonium Chloride. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]Health Canada (DPD) · 00535230 · revised March 22, 2025
- [2]FDA DailyMed · 0067f67a-daeb-4b… · revised July 13, 2023 [PDF]
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.